SCHEMBL13293284

COC(=O)N[C@@H](CON1CCC[C@H]1c1ncc(-c2ccc(C#Cc3ccc4c(c3)CCc3nc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c3-4)c(F)c2)[nH]1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 8)

	gene	UniProt	supporting neighbours	confidence
▸	CYP3A4	P08684	7/20	0.48

▸	CYP2C9	P11712	5/20	0.48

▸	NR1I2	O75469	2/20	0.48

▸	KCNH2	Q12809	2/20	0.48

▸	ABCB11	O95342	1/20	0.48

▸	OPRK1	P41145	1/20	0.48

▸	CYP1A2	P05177	3/20	0.48

▸	CYP2D6	P10635	2/20	0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL10146172	0.91	CYP3A4 (0.53)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL12068532	0.85	CYP3A4 (0.52)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL10146147	0.84	CYP3A4 (0.59)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL10144883	0.84	CYP3A4 (0.59)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL10146156	0.84	CYP3A4 (0.67)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL10177585	0.82	CYP3A4 (0.57)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL15370110	0.81	CYP3A4 (0.61)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL10146168	0.81	CYP3A4 (0.66)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL12069592	0.80	CYP3A4 (0.54)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL16181003	0.80	CYP3A4 (0.61)	CYP3A4CYP2C9NR1I2KCNH2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2010065668-A1	INHIBITORS OF HCV NS5A	PRESIDIO PHARMACEUTICALS, INC. (US)	2010-06-10	—	—	WO	disclosed